Jean-Paul Thiery (Jean P Thiery, Jean Paul Thiery)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Venues

Cancer research

NPJ precision oncology

Nature communications

Development (Cambridge, England)

Guangzhou Regenerative Medicine and Health Guangdong laboratory

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Guangzhou Regenerative Medicine and Health Guangdong laboratory Jun 01 2019

China

Head :: Development and Cancer

Publications

Jean-Paul Thiery, Guojun Sheng, Xiaodong Shu, Raymond B Runyan
How studies in developmental epithelial-mesenchymal transition and mesenchymal-epithelial transition inspired new research paradigms in biomedicine. Development (Cambridge, England) 151 (3) (2024)
Jean-Paul Thiery, Guojun Sheng, Xiaodong Shu, Raymond B Runyan
How studies in developmental epithelial-mesenchymal transition and mesenchymal-epithelial transition inspired new research paradigms in biomedicine. Development (Cambridge, England) 151 (3) (2024)
Lei Zhang, Yuqing Li, Lingli Zhou, Houhong Zhou, Liefu Ye, Tong Ou, Huaishan Hong, Shiwen Zheng, Ziyu Zhou, Kang Wu, Zeqin Yan, Jean-Paul Thiery, Jun Cui, Song Wu
The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response. Cancer research (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Jean Agnetti, Vanessa Bou Malham, Christophe Desterke, Nassima Benzoubir, Juan Peng, Sophie Jacques, Souad Rahmouni, Emanuel Di Valentin, Tuan-Zea Tan, Didier Samuel, Jean-Paul Thiery, Ama Gassama-Diagne
PI3Kδ activity controls plasticity and discriminates between EMT and stemness based on distinct TGFβ signaling. Communications biology 5 (1) (2022)
Valerie S LeBleu, Jean-Paul Thiery
The Continuing Search for Causality between Epithelial-to-Mesenchymal Transition and the Metastatic Fitness of Carcinoma Cells. Cancer research 82 (8) (2022)
Darwesh Mohideen Kaderbatcha Aladin, Yeh Shiu Chu, Shuo Shen, Robert Charles Robinson, Sylvie Dufour, Virgile Viasnoff, Nicolas Borghi, Jean-Paul Thiery
Extracellular domains of E-cadherin determine key mechanical phenotypes of an epithelium through cell- and non-cell-autonomous outside-in signaling. PloS one 16 (12) (2021)
Vlada S Rozova, Ayad G Anwer, Anna E Guller, Hamidreza Aboulkheyr Es, Zahra Khabir, Anastasiia Ivanovna Sokolova, Maxim U Gavrilov, Ewa M Goldys, Majid Ebrahimi Warkiani, Jean-Paul Thiery, Andrei V Zvyagin
Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness. PLoS computational biology 17 (7) (2021)
Claudia Koch, Andra Kuske, Simon A Joosse, Gökhan Yigit, George Sflomos, Sonja Thaler, Daniel J Smit, Stefan Werner, Kerstin Borgmann, Sebastian Gärtner, Parinaz Mossahebi Mohammadi, Laura Battista, Laure Cayrefourcq, Janine Altmüller, Gabriela Salinas-Riester, Kaamini Raithatha, Arne Zibat, Yvonne Goy, Leonie Ott, Kai Bartkowiak, Tuan-Zea Tan, Qing Zhou, Michael R Speicher, Volkmar Müller, Tobias M Gorges, Manfred Jücker, Jean-Paul Thiery, Cathrin Brisken, Sabine Riethdorf, Catherine Alix-Panabières, Klaus Pantel
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. EMBO molecular medicine 12 (9) (2020)
Jing Yang, Parker Antin, Geert Berx, Cédric Blanpain, Thomas Brabletz, Marianne Bronner, Kyra Campbell, Amparo Cano, Jordi Casanova, Gerhard Christofori, Shoukat Dedhar, Rik Derynck, Heide L Ford, Jonas Fuxe, Antonio García de Herreros, Gregory J Goodall, Anna-Katerina Hadjantonakis, Ruby Y J Huang, Chaya Kalcheim, Raghu Kalluri, Yibin Kang, Yeesim Khew-Goodall, Herbert Levine, Jinsong Liu, Gregory D Longmore, Sendurai A Mani, Joan Massagué, Roberto Mayor, David McClay, Keith E Mostov, Donald F Newgreen, M Angela Nieto, Alain Puisieux, Raymond B Runyan, Pierre Savagner, Ben Stanger, Marc P Stemmler, Yoshiko Takahashi, Masatoshi Takeichi, Eric Théveneau, Jean-Paul Thiery, Erik W Thompson, Robert A Weinberg, Elizabeth D Williams, Jianhua Xing, Binhua P Zhou, Guojun Sheng, null null
Guidelines and definitions for research on epithelial-mesenchymal transition. Nature reviews. Molecular cell biology 21 (6) (2020)
Hamidreza Aboulkheyr Es, Bahareh Bigdeli, Sareh Zhand, Amir Reza Aref, Jean-Paul Thiery, Majid Ebrahimi Warkiani
Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells. Journal of cellular physiology 236 (5) (2020)
Duan-Qing Pei, Xiaodong Shu, Ama Gassama-Diagne, Jean-Paul Thiery
Mesenchymal-epithelial transition in development and reprogramming. Nature cell biology 21 (1) (2019)
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan-Zea Tan, Azad Saei, Patrick William Jaynes, Chandra Shekhar Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, Camelia Radulescu, Peter Ten Dijke, Pieter Johan Adam Eichhorn, Jean-Paul Thiery
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature communications 10 (1) (2019)
Vignesh Sundararajan, Ming Tan, Tuan-Zea Tan, Jieru Ye, Jean-Paul Thiery, Ruby Yun-Ju Huang
SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition. Scientific reports 9 (1) (2019)
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan-Zea Tan, Azad Saei, Patrick William Jaynes, Chandra Shekhar Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, Camelia Radulescu, Peter Ten Dijke, Pieter Johan Adam Eichhorn, Jean-Paul Thiery
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature communications 10 (1) (2019)
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z Rizvi, Rosa L Frias, Jean-Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Braye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry De Baere, Lambros Tselikas, Eric Solary, Eric Angevin, Alexander M Eggermont, Fabrice Andre, Christophe Massard, Ken A Olaussen, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (1) (2019)
Stéphane Terry, Abderemane Abdou, Agnete S T Engelsen, Stéphanie Buart, Philippe Dessen, Stéphanie Corgnac, Davi Collares, Guillaume Meurice, Gro Gausdal, Veronique Baud, Pierre Saintigny, James B Lorens, Jean-Paul Thiery, Fathia Mami-Chouaib, Salem Chouaib
AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity. Cancer immunology research 7 (11) (2019)
Ajay Balakrishnan, Deepak Koppaka, Abhishek Anand, Barnali Deb, Gianluca Grenci, Virgile Viasnoff, Erik W Thompson, Harsha Gowda, Ramray Bhat, Annapoorni Rangarajan, Jean-Paul Thiery, K Govind Babu, Prashant Kumar
Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival. Scientific reports 9 (1) (2019)
Jane Antony, Elisa Zanini, Zoe Kelly, Tuan-Zea Tan, Evdoxia Karali, Mohammad Alomary, Youngrock Jung, Katherine Nixon, Paula Cunnea, Christina Fotopoulou, Andrew Paterson, Sushmita Roy-Nawathe, Gordon B Mills, Ruby Yun-Ju Huang, Jean-Paul Thiery, Hani Gabra, Chiara Recchi
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. EMBO reports 19 (8) (2018)
Antoun Al Absi, Hannah Wurzer, Coralie Guerin, Celine Hoffmann, Flora Moreau, Xianqing Mao, Joshua Brown-Clay, Rémi Petrolli, Carla Pou Casellas, Monika Dieterle, Jean-Paul Thiery, Salem Chouaib, Guy Berchem, Bassam Janji, Clément Thomas
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity. Cancer research 78 (19) (2018)
Bee Luan Khoo, Gianluca Grenci, Tengyang Jing, Ying Bena Lim, Soo Chin Lee, Jean-Paul Thiery, Jongyoon Han, Chwee Teck Lim
Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment. Science advances 2 (7) (2016)

Jean-Paul Thiery.css-eqlu8i{font-size:small;padding-left:4px;} (Jean P Thiery, Jean Paul Thiery)

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Paul Thiery (Jean P Thiery, Jean Paul Thiery)